Title: The Analysis of Clinical Symptom Relief and Quality of Life Improvement of Hp Positive Peptic Ulcer Patients with Rabeprazole-based Triple Therapy
Abstract: Objective To study the value of Rabeprazole-based triple therapy in relieving the clinical symptoms and improving the quality of life of patients with Helicobacter pylori(Hp) Positive Peptic Ulcer. Methods 94 cases of Hp Positive Peptic Ulcer patients treated in our hospital from February 2013 to October 2013 was selected and they are randomly divided into the control group and the observation group, and each group has 47 cases. The control group were treated with omeprazole, clarithromycin, amoxicillin triple therapy, while the observation group were treated with Ray Bella, clarithromycin, amoxicillin triple therapy. Then the two groups' treatment efficiency and quality of life score(QOL) were compared. Results The effective rate of observation group was 95.7%, which was significantly higher than that of the control group(8.09%), and the difference was statistically significant(P0.05); The score of QOL in the observation group(1.25±0.32)was significantly lower than that in the control group(1.72±0.28), which was statistically significant(P0.05). Conclusion Rabeprazole-based Triple Therapy can effectively relieve the clinical symptoms of Hp positive peptic ulcer patients and improve the quality of life, which can be available in clinic.
Publication Year: 2015
Publication Date: 2015-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot